Bioreactor Design and Engineering for Cultivated Meat Manufacturing

Area of Science:

• Biotechnology and Bioprocess Engineering
• Cellular Agriculture
• Tissue Engineering

Background:

• Industrial biotechnology has seen limited innovation in bioreactor design, primarily using stirred-tank and bubble-column reactors for microbial fermentation.
• Pharmaceutical biotechnology utilizes various systems for eukaryotic cells, optimized for biomolecule production, not cellular biomass.
• Tissue engineering advanced bioreactor concepts, particularly perfusion systems, for regenerative medicine applications.

Purpose of the Study:

• To explore the adaptation of existing bioreactor technologies for cellular agriculture.
• To identify key challenges and opportunities in scaling up animal cell production for cultivated meat.
• To highlight the need for interdisciplinary collaboration in developing food-relevant bioprocessing.

Main Methods:

• Review of established bioreactor types in industrial and pharmaceutical biotechnology.
• Analysis of perfusion bioreactor advancements in tissue engineering.
• Conceptual framework for applying bioprocessing knowledge to cellular agriculture.

Main Results:

• Current bioreactor systems are not optimized for the high-volume, cost-efficient production of cellular biomass required for cultivated meat.
• Perfusion bioreactor technology from tissue engineering provides a promising foundation for structured cultivated meat manufacturing.
• Significant interdisciplinary collaboration is essential for successful implementation.

Conclusions:

• Transitioning from high-value pharmaceutical production to cost-efficient food production necessitates significant bioprocess innovation.
• Leveraging tissue engineering's perfusion bioreactor advancements is crucial for structured cultivated meat production.
• Achieving scalable and affordable cultivated meat requires a multidisciplinary approach integrating engineering, biology, and food science.